Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors	Adenoma, Islet Cell, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, Thoracic Neoplasms, Tumor Virus Infections, adenocarcinoma, adenoma, appendix adenocarcinoma, carcinoma, cutaneous neuroendocrine carcinoma, cystic, mucinous, and serous neoplasm, endocrine system disorder, epithelial neoplasm, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant mesothelioma, mesothelial neoplasm, mesothelioma, mucinous adenocarcinoma, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, otorhinolaryngologic disease, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor, pleural neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, viral infectious disease	Active, not recruiting	Phase 2	2026-09-14		NCT03074513

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
M.D. Anderson Cancer Center	1145
National Cancer Institute (NCI)	3015

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
M D Anderson Cancer Center	Houston	United States	667